desethylamiodarone

Known as: Methanone, (2-butyl-3-benzofuranyl)(4-(2-(ethylamino)ethoxy)-3,5-diiodophenyl)-, N-desethylamiodarone, deethylamiodarone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
OBJECTIVE Amiodarone, a class III antiarrhythmic agent, is a potent vasodilator in vivo. Its main metabolite, N… (More)
Is this relevant?
1995
1995
The antiarrhythmic drug amiodarone and its metabolite desethylamiodarone, were radiolabeled with sodium [123I]-iodide in > 98… (More)
Is this relevant?
1991
1991
Amiodarone is a clinically effective antiarrhythmic drug shown to cause lung damage in humans and animals. While the mechanism of… (More)
Is this relevant?
1990
1990
Myocardial amiodarone and desethylamiodarone concentrations were measured at multiple sites in the explanted heart in four… (More)
Is this relevant?
1989
1989
Associated with amiodarone use is pneumonitis which may progress to life-threatening pulmonary fibrosis. Desethylamiodarone, a… (More)
Is this relevant?
1988
1988
Twelve patients with frequent ventricular premature depolarizations (VPDs) received amiodarone, 600 mg/day, for up to 8 weeks. On… (More)
Is this relevant?
1987
1987
The distribution of the antiarrhythmic drug amiodarone and its principal lipophilic metabolite, desethylamiodarone, was… (More)
Is this relevant?
1987
1987
It has been suggested that some of the effects of long-term amiodarone therapy may be due to accumulation of a metabolite… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1987
1987
Because the value of monitoring amiodarone plasma concentrations remains undefined, this study was performed to evaluate its role… (More)
Is this relevant?
1982
1982
Desethylamiodarone has been identified as the principal lipophilic metabolite of amiodarone present in plasma specimens from… (More)
Is this relevant?